| P50 | author | José Luis Piñana | Q53359496 |
| | Víctor Vinuesa | Q61091625 |
| P2093 | author name string | Guillermo Sanz | |
| | David Navarro | |
| | Estela Giménez | |
| | Carlos Solano | |
| | Miguel Salavert | |
| | Ignacio Lorenzo | |
| | Jaime Sanz | |
| | María Dolores Gómez | |
| | Juan Montoro | |
| | Ariadna Pérez | |
| | Silvia Madrid | |
| | Juan Carlos Hernández-Boluda | |
| | Eva María González | |
| P2860 | cites work | Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus | Q27021622 |
| | Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. | Q30373149 |
| | Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host | Q30395200 |
| | Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients | Q30400403 |
| | Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients | Q30402383 |
| | Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls | Q33409354 |
| | Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections | Q33714717 |
| | 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host | Q34390072 |
| | Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index | Q36578729 |
| | Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome | Q37726073 |
| | Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. | Q37846281 |
| | European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. | Q38077827 |
| | Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice | Q38269154 |
| | The benefit of influenza vaccination after bone marrow transplantation | Q39199964 |
| | Comparison of the performance of 2 commercial multiplex PCR platforms for detection of respiratory viruses in upper and lower tract respiratory specimens | Q41459364 |
| | Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients | Q44060659 |
| | Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience | Q45734202 |
| | Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation | Q45735386 |
| | Respiratory virus infections in bone marrow transplant recipients: the European perspective | Q45741856 |
| | Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience | Q45741859 |
| | Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients | Q45780123 |
| | Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. | Q46142983 |
| | Epidemiologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study | Q47444851 |
| | A Double Blind Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Adult Solid Organ Transplant Recipients. | Q49668639 |
| | Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. | Q50651452 |
| | Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. | Q54204894 |
| | Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell Transplantation | Q58789095 |
| | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 |
| | Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients | Q70557635 |
| | Vaccination of hematopoietic cell transplant recipients | Q84794978 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 1894-1903 | |
| P577 | publication date | 2019-05-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study | |
| P478 | volume | 68 | |